TABLE OF CONTENTS:

    Instead of introduction: an anniversary e-mail, signal of overviews

    Chapter .I. ON THE BEES WORLD

    I.1.CURIOSITIES OF BEES LIFE

    I.2.KNOWN AND UNKNOWN ABOUT BEE GIFTS

    Chapter II. APITHERAPY AND APITHERAPEUTIST

    II.1. APITHERAPY BETWEEN THEORY AND PRACTICE

    II.2. THE APITHERAPEUTIST

    Chapter III. CONTRIBUTIONS FOR DEVELOPING THE APITHERAPY

    III.1. MASTERS, DOCTORATES AND POSTDOCTORAL STUDIES

    III.2. EDUCATIONAL CONTRIBUTIONS

    III.3. PUBLISHING CONTRIBUTIONS

    III.3.1. PUBLISHED BOOKS

    III.3.2. PUBLISHED STUDIES AND ARTICLES

    Chapter 4. PRODUCTION OF HONEY BEE THERAPEUTIC PRODUCTS

    IV.1. THE NEED OF HONEY BEE THERAPEUTIC PRODUCTS

    IV.2. THE HERITAGE

    IV.3. BIOCHEMISTRY OF HONEY BEE PRODUCTS, SUPPORT OF HONEY BEE THERAPEUTIC RODUCTS PRODUCED BY APITHERAPY MEDUCAL CENTER

    IV.3.1.BEE PRODUCTS. THEIR QUICK LOOK

    IV.3.1.1. HONEY

    IV.3.1.2. ROYAL JELLY

    IV.3.1.3. APILARNIL

    IV.3.1.4. POLLEN

    IV.3.1.5. BEE BREAD

    IV.3.1.6. PROPOLIS

    IV.3.1.7. WAX

    IV.3.1.8. BEE VENOM

    IV.4. HONEY BEE PHARMACY AND HUMAN CELL

    IV.4.1.HONEY BEE BIOMOLECULES – HUMAN CORRESPONDENCE

    IV.4.2. HONEY BEE THERAPEUTIC PRODUCTS, HUMAN CELL AND EXTRACELLULAR ENVIRONMENT

    IV.5. CHARACTERISTICS OF HONEY BEE THERAPEUTIC PRODUCTS PRODUCED BY APITHERAPY MEDICAL CENTER

    IV.5.1. BINOMIAL CHARACTER OF HONEY BEE THERAPEUTIC PRODUCTS

    IV.5.2. THREE DIMENSIONAL NATURE OF HONEY BEE THERAPEUTIC PRODUCTS

    IV.5.3. SYNERGISTIC NATURE OF HONEY BEE THERAPEUTIC PRODUCTS

    IV.5.3.1. BIOCHEMICAL OFFER SYNERGY OF HONEY BEE THERAPEUTIC PRODUCTS

    IV.5.3.2. CLINICAL ACTION SYNERGY THROUGH PRESENCE SYNERGY

    IV.5.3.2.1. AN EXAMPLE OF CLINICAL SYNERGY IN AUTOIMMUNITY

    IV.5.3.3. HONEY BEE THERAPEUTIC PRODUCTS AND HONEY BEE STEM CELLS

    IV.5.4. HONEY BEE THERAPEUTIC PRODUCTS PRODUCED BY APITHERAPY MEDICAL CENTER

    Chapter V. OUR METHOD IN APIPROPHYLAXIS AND APITHERAPY

    V.1. HEALTH, DISEASE, DIAGNOSIS

    V.1.1. CLASSIFYNG THE DISEASES

    V.2. CLINICAL APITHERAPY

    V.3. CLINICAL APIPROPHYLAXIS

    Chapter VI. – NOT TRANSLATED

    Chapter VII. – The Laboratory Tests

    VII.1. THE LABORATORY TESTS. SERUM PROTEIN ELECTROPHORESIS, IONIZED CALCIUM AND REBALANCING PLASMA PROTEINS

    VII.1.2. ROUTINE LABORATORY TESTS

    VII.1.3 SPECIALIST LABORATORY TESTS

    VII.2. THE PROTEINS AND THE HOMEOSTASIS

    VII.2.1. PROTEINAEMIA, TOTAL PROTEINS AND DYSPROTEINAEMIA.

    VII.2.2. THE TOTAL PROTEINS – VALUES CONSIDERED TO BE NORMAL AND VALUES THAT WE PROPOSE TO BE ADOPTED AS NORMAL

    VII.3. THE SERUM PROTEIN ELECTROPHORESIS AND IONIZED CALCIUM, VALUABLE TESTS FOR HEALTH

    VII.3.1. ILLUSTRATIVE CLINICAL CASES FOR ESTABLISHING THE LIMITS OF THE NORMAL VALUES OF TOTAL AND SERUM PROTEINS

    Uterine fibroma, autoimmune disease – 35 years old/ 1,56m/ 44 kg

    Polycystic ovary  18 years old/ 1,60 m/ 46 kg

    Glioblastoma multiforme – Standard therapy and apitherapy Apitherapy clinical breakthrough